Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Coloplast A/S
  6. Summary
    COLO B   DK0060448595

COLOPLAST A/S

(COLO B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
10/13/2021 10/14/2021 10/15/2021 10/18/2021 10/19/2021 Date
1008.5(c) 1001(c) 1019.5(c) 1024(c) 1050.5(c) Last
99 899 139 262 110 215 107 351 199 031 Volume
+1.30% -0.74% +1.85% +0.44% +2.59% Change
More quotes
Estimated financial data (e)
Sales 2021 19 357 M 3 027 M 3 027 M
Net income 2021 4 794 M 750 M 750 M
Net Debt 2021 1 770 M 277 M 277 M
P/E ratio 2021 46,7x
Yield 2021 1,83%
Sales 2022 20 991 M 3 283 M 3 283 M
Net income 2022 5 210 M 815 M 815 M
Net Debt 2022 1 991 M 311 M 311 M
P/E ratio 2022 42,8x
Yield 2022 1,99%
Capitalization 223 B 34 953 M 34 943 M
EV / Sales 2021 11,6x
EV / Sales 2022 10,7x
Nbr of Employees 12 500
Free-Float 57,4%
More Financials
Company
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (46.7%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (40.6%): bags and equipment used following intestinal operations; - wound care and skincare products (12.7%): wound dressings, bandages, creams and... 
More about the company
Ratings of Coloplast A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about COLOPLAST A/S
10/11COLOPLAST A/S : Invitation
PU
09/15Francis Medical, Inc announced that it has received $55 million in funding from Solas B..
CI
09/14Francis Medical, Inc announced that it expects to receive $55 million in funding
CI
09/08COLOPLAST A/S : opens new factory in Costa Rica
AQ
09/08Coloplast Opens New Factory in Costa Rica
CI
08/26COLOPLAST A/S : - Trading in Coloplast shares by board members, executives or associated p..
AQ
08/26COLOPLAST A/S : - Announcement no. 05/2021 - Financial Calendar 2021-22
AQ
08/24Coloplast SenSura® Mio is Extended Wear in the US
GL
08/23COLOPLAST A/S : - Transactions in connection with share buy-back programme, week 33 (progr..
AQ
08/18COLOPLAST A/S : 9M 2020/21 roadshow presentation
PU
08/18COLOPLAST A/S : 9M 2020/21 Interim Financial Report
PU
08/18COLOPLAST A/S : delivers 11% organic growth in Q3 and an EBIT margin of 33%
AQ
08/18COLOPLAST A/S : - Announcement no. 04/2021 – Interim Financial Report, 9M 2020/21
AQ
08/18Coloplast A/S Provides Earnings Guidance for the Year 2020/2021
CI
08/16COLOPLAST A/S : - Transactions in connection with share buy-back programme, week 32
AQ
More news
News in other languages on COLOPLAST A/S
10/14EFFECTEN-SPIEGEL AG : Net Asset Value zum 30.09.2021
08/18STOCK MARKET PARIS : Quand les investisseurs ont le pied sur la pédale de frein
08/18EN DIRECT DES MARCHES : STMicro, Carlsberg, BHP, Alibaba, Moderna, Alcon, Novacyt...
07/14DGAP-NAV : Effecten-Spiegel AG: Net Asset Value
06/25OPINIONES DE LOS ANALISTAS DEL DÍA : Fluidra, Nokia, Logitech, Puma, Focus Home Interactiv..
More news
Analyst Recommendations on COLOPLAST A/S
More recommendations
Chart COLOPLAST A/S
Duration : Period :
Coloplast A/S Technical Analysis Chart | COLO B | DK0060448595 | MarketScreener
Technical analysis trends COLOPLAST A/S
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 1 050,50 DKK
Average target price 1 043,50 DKK
Spread / Average Target -0,67%
EPS Revisions
Managers and Directors
Kristian Villumsen President & Chief Executive Officer
Anders Lonning-Skovgaard Chief Financial Officer & Executive Vice President
Lars Søren Rasmussen Chairman
Oliver Johansen Senior VP-Global Research & Development
Allan Rasmussen Executive Vice President-Global Operations